IBDEI1GP ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23381,1,4,0)
 ;;=4^D05.11
 ;;^UTILITY(U,$J,358.3,23381,2)
 ;;=^5001930
 ;;^UTILITY(U,$J,358.3,23382,0)
 ;;=D05.12^^105^1173^24
 ;;^UTILITY(U,$J,358.3,23382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23382,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ of Breast,Left
 ;;^UTILITY(U,$J,358.3,23382,1,4,0)
 ;;=4^D05.12
 ;;^UTILITY(U,$J,358.3,23382,2)
 ;;=^5001931
 ;;^UTILITY(U,$J,358.3,23383,0)
 ;;=D05.81^^105^1173^4
 ;;^UTILITY(U,$J,358.3,23383,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23383,1,3,0)
 ;;=3^Carcinoma in Situ of Breast,Right NEC
 ;;^UTILITY(U,$J,358.3,23383,1,4,0)
 ;;=4^D05.81
 ;;^UTILITY(U,$J,358.3,23383,2)
 ;;=^5001933
 ;;^UTILITY(U,$J,358.3,23384,0)
 ;;=D05.82^^105^1173^2
 ;;^UTILITY(U,$J,358.3,23384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23384,1,3,0)
 ;;=3^Carcinoma in Situ of Breast,Left NEC
 ;;^UTILITY(U,$J,358.3,23384,1,4,0)
 ;;=4^D05.82
 ;;^UTILITY(U,$J,358.3,23384,2)
 ;;=^5001934
 ;;^UTILITY(U,$J,358.3,23385,0)
 ;;=D06.9^^105^1173^6
 ;;^UTILITY(U,$J,358.3,23385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23385,1,3,0)
 ;;=3^Carcinoma in Situ of Cervix,Unspec
 ;;^UTILITY(U,$J,358.3,23385,1,4,0)
 ;;=4^D06.9
 ;;^UTILITY(U,$J,358.3,23385,2)
 ;;=^5001941
 ;;^UTILITY(U,$J,358.3,23386,0)
 ;;=D06.0^^105^1173^7
 ;;^UTILITY(U,$J,358.3,23386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23386,1,3,0)
 ;;=3^Carcinoma in Situ of Endocervix
 ;;^UTILITY(U,$J,358.3,23386,1,4,0)
 ;;=4^D06.0
 ;;^UTILITY(U,$J,358.3,23386,2)
 ;;=^5001938
 ;;^UTILITY(U,$J,358.3,23387,0)
 ;;=D06.1^^105^1173^8
 ;;^UTILITY(U,$J,358.3,23387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23387,1,3,0)
 ;;=3^Carcinoma in Situ of Exocervix
 ;;^UTILITY(U,$J,358.3,23387,1,4,0)
 ;;=4^D06.1
 ;;^UTILITY(U,$J,358.3,23387,2)
 ;;=^5001939
 ;;^UTILITY(U,$J,358.3,23388,0)
 ;;=D09.0^^105^1173^1
 ;;^UTILITY(U,$J,358.3,23388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23388,1,3,0)
 ;;=3^Carcinoma in Situ of Bladder
 ;;^UTILITY(U,$J,358.3,23388,1,4,0)
 ;;=4^D09.0
 ;;^UTILITY(U,$J,358.3,23388,2)
 ;;=^267742
 ;;^UTILITY(U,$J,358.3,23389,0)
 ;;=C90.30^^105^1173^99
 ;;^UTILITY(U,$J,358.3,23389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23389,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
 ;;^UTILITY(U,$J,358.3,23389,1,4,0)
 ;;=4^C90.30
 ;;^UTILITY(U,$J,358.3,23389,2)
 ;;=^5001759
 ;;^UTILITY(U,$J,358.3,23390,0)
 ;;=Z85.818^^105^1173^82
 ;;^UTILITY(U,$J,358.3,23390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23390,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Lip/Oral Cavity/Pharynx
 ;;^UTILITY(U,$J,358.3,23390,1,4,0)
 ;;=4^Z85.818
 ;;^UTILITY(U,$J,358.3,23390,2)
 ;;=^5063439
 ;;^UTILITY(U,$J,358.3,23391,0)
 ;;=Z85.01^^105^1173^78
 ;;^UTILITY(U,$J,358.3,23391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23391,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Esophagus
 ;;^UTILITY(U,$J,358.3,23391,1,4,0)
 ;;=4^Z85.01
 ;;^UTILITY(U,$J,358.3,23391,2)
 ;;=^5063395
 ;;^UTILITY(U,$J,358.3,23392,0)
 ;;=Z85.028^^105^1173^88
 ;;^UTILITY(U,$J,358.3,23392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23392,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Stomach
 ;;^UTILITY(U,$J,358.3,23392,1,4,0)
 ;;=4^Z85.028
 ;;^UTILITY(U,$J,358.3,23392,2)
 ;;=^5063397
 ;;^UTILITY(U,$J,358.3,23393,0)
 ;;=Z85.038^^105^1173^80
 ;;^UTILITY(U,$J,358.3,23393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23393,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Large Intestine
